Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01823432 · ClinicalTrials.gov registry record
Genetic Risks for Bicuspid Aortic Valve Disease
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 454
- Enrollment target
NCT01823432 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 454 participants.
The verdict
NCT01823432 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 454 participants
- Enrollment target
Study Summary
Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV patients are also at high risk to develop aneurysms of the ascending aorta, which may lead to aortic dissections. Dr. Prakash and his colleagues plan to use individual genetic information to identify persons with BAV who are at high risk for complications and to customize therapies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 454 participants |
| Start Date | 2012-03 |
| Est. Completion | 2022-09-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01823432
The ClinicalTrials.gov registry entry for NCT01823432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 454 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01823432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01823432 about?
NCT01823432 is a clinical study titled "Genetic Risks for Bicuspid Aortic Valve Disease". Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV pat...
What is the current status of trial NCT01823432?
This trial is currently completed. The enrollment target is 454 participants. The study started on 2012-03. Estimated completion is 2022-09-19.
Who is sponsoring clinical trial NCT01823432?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.